Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 301

1.

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.

Lambert M, Lupien PJ, Gagné C, Lévy E, Blaichman S, Langlois S, Hayden M, Rose V, Clarke JT, Wolfe BM, Clarson C, Parsons H, Stephure DK, Potvin D, Lambert J.

Pediatrics. 1996 May;97(5):619-28.

PMID:
8628597
3.

Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.

Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO.

Pediatrics. 2005 Sep;116(3):682-8.

PMID:
16140708
4.

A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin.

Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L.

Clin Ther. 2002 Jan;24(1):112-25.

PMID:
11833826
5.

Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia.

Prisant LM, Downton M, Watkins LO, Schnaper H, Bradford RH, Chremos AN, Langendörfer A.

Am J Cardiol. 1996 Aug 15;78(4):420-4.

PMID:
8752186
6.

Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.

Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.

Diabetes Obes Metab. 2000 Dec;2(6):355-62.

PMID:
11225965
7.
8.
9.

Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.

Stalenhoef AF, Lansberg PJ, Kroon AA, Kortmann B, De Haan AF, Stuyt PM, Kastelein JJ.

J Intern Med. 1993 Jul;234(1):77-82.

PMID:
8326293
10.

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.

Huijgen R, Abbink EJ, Bruckert E, Stalenhoef AF, Imholz BP, Durrington PN, Trip MD, Eriksson M, Visseren FL, Schaefer JR, Kastelein JJ; Triple Study Group.

Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.

PMID:
20435231
11.

Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.

McPherson R, Bedard J, Connelly P, Curnew G, Davignon J, Echenberg D, Lavin P, Leiter L, Lenis J, McQueen M, et al.

Clin Ther. 1992 Mar-Apr;14(2):276-91.

PMID:
1611649
12.

Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.

Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G, et al.

Can J Cardiol. 1993 Jun;9(5):405-12.

PMID:
8348392
13.

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, Gould AL, Hesney M, Higgins J, Hurley DP, et al.

Arch Intern Med. 1991 Jan;151(1):43-9.

PMID:
1985608
14.

Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

Ose L, Davidson MH, Stein EA, Kastelein JJ, Scott RS, Hunninghake DB, Campodonico S, Insull W, Escobar ID, Schrott HG, Stepanavage ME, Wu M, Tate AC, Melino MR, Mercuri M, Mitchel YB.

Clin Cardiol. 2000 Jan;23(1):39-46.

16.

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia.

Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, Mountney J.

Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1527-31.

17.

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.

Havel RJ, Hunninghake DB, Illingworth DR, Lees RS, Stein EA, Tobert JA, Bacon SR, Bolognese JA, Frost PH, Lamkin GE, et al.

Ann Intern Med. 1987 Nov;107(5):609-15.

PMID:
3662274
18.

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

Davidson M, McKenney J, Stein E, Schrott H, Bakker-Arkema R, Fayyad R, Black D.

Am J Cardiol. 1997 Jun 1;79(11):1475-81.

PMID:
9185636
19.

Reduction of LDL cholesterol in patients with primary hypercholesterolemia by SCH 48461: results of a multicenter dose-ranging study.

Dujovne CA, Bays H, Davidson MH, Knopp R, Hunninghake DB, Stein EA, Goldberg AC, Jones P, Lipka LJ, Cuffie-Jackson C.

J Clin Pharmacol. 2001 Jan;41(1):70-8.

PMID:
11144997
20.

One year experience in the treatment of familial hypercholesterolaemia with simvastatin.

Quiney J, Watts GF, Kerr-Muir M, Slavin B, Lewis B.

Postgrad Med J. 1992 Jul;68(801):575-80.

Supplemental Content

Support Center